• Home
  • MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas.

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas.

Author List
Stopfer LE, Rettko NJ, Leddy O, Mesfin JM, Brown E, Winski S, Bryson B, Wells JA, White FM
Publication
Proceedings of the National Academy of Sciences of the United States of America
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366100699
Publication Year
2022
PubMed ID
36454758
Publication Title
Stopfer LE, Rettko NJ, Leddy O, Mesfin JM, Brown E, Winski S, Bryson B, Wells JA, White FM. MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas. Proc Natl Acad Sci U S A. 2022 12 06; 119(49):e2208900119.